We are live on ! Find out more
ICM

Invenomic Capital Management Portfolio holdings

AUM $1.67B Turnover 44.44%
1-Year Est. Return 1.43%
This Fund
S&P 500
This Quarter Est. Return
+1.91%
1 Year Est. Return
-1.43%
3 Year Est. Return
-6.61%
5 Year Est. Return
-27.23%
10 Year Est. Return
–
AUM
$1.67B
AUM Growth
-$505M
Cap. Flow
-$520M
Cap. Flow %
-31.03%
Top 10 Hldgs %
29.21%
Holding
171
New
21
Increased
23
Reduced
68
Closed
55
Avg Time Held Equity + Options
1.1 years
Top 10 Avg Time Held Equity + Options
0.6 years
Top 20 Avg Time Held Equity + Options
0.8 years
Avg Time Held Equity only
1.1 years
Top 10 Avg Time Held Equity only
0.6 years
Top 20 Avg Time Held Equity only
0.8 years

Top Sells

Rank Stock Value
1
CHRD icon
Chord Energy
CHRD
+$73.2M
2
TFX icon
Teleflex
TFX
+$52.2M
3
AKAM icon
Akamai
AKAM
+$46.6M
4
RNG icon
RingCentral
RNG
+$30.2M
5
HAE icon
Haemonetics
HAE
+$28.8M

Sector Composition

Rank Sector Weight
1 Technology 32.19%
2 Healthcare 19.57%
3 Industrials 14.44%
4 Consumer Discretionary 10.33%
5 Communication Services 7.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
HUBS icon
51
HubSpot
HUBS
$11.9B
$11.9M 0.71%
65,146
+38,928
+148% +$8.14M
2026 Q1
1 quarter
SSTK icon
52
Shutterstock
SSTK
$170M
$11.5M 0.69%
822,696
-36,941
-4% -$582K
2023 Q2
12 quarters
CAL icon
53
Caleres
CAL
$453M
$11.2M 0.67%
902,633
-201,380
-18% -$2.61M
2025 Q1
5 quarters
IART icon
54
Integra LifeSciences
IART
$1.05B
$10.4M 0.62%
579,036
-432,279
-43% -$6.05M
2025 Q2
4 quarters
HELE icon
55
Helen of Troy
HELE
$691M
$10.4M 0.62%
357,451
-292,008
-45% -$6.91M
2024 Q3
7 quarters
MKTX icon
56
MarketAxess Holdings
MKTX
$5.79B
$10.3M 0.61%
+90,441
New +$12.9M
2026 Q2
0 quarters
MTN icon
57
Vail Resorts
MTN
$5.45B
$10.2M 0.61%
75,225
-35,318
-32% -$4.6M
2025 Q1
5 quarters
FLGT icon
58
Fulgent Genetics
FLGT
$587M
$10.2M 0.61%
498,287
-112,031
-18% -$1.9M
2026 Q1
1 quarter
MATV icon
59
Mativ Holdings
MATV
$644M
$10.2M 0.61%
1,348,326
-585,103
-30% -$5.04M
2025 Q1
5 quarters
FLO icon
60
Flowers Foods
FLO
$1.3B
$10M 0.6%
1,271,875
+121,536
+11% +$973K
2025 Q4
2 quarters
SSNC icon
61
SS&C Technologies
SSNC
$19.8B
$9.88M 0.59%
+159,291
New +$10.8M
2026 Q2
0 quarters
DNOW icon
62
DNOW Inc
DNOW
$2.72B
$9.81M 0.59%
+756,582
New +$9.82M
2026 Q2
0 quarters
ACH icon
63
Accendra Health
ACH
$20.1M
$9.62M 0.57%
2,812,474
-556,501
-17% -$1.73M
2025 Q3
3 quarters
M icon
64
Macy's
M
$6.33B
$9.36M 0.56%
397,367
-653,956
-62% -$13.7M
2023 Q4
10 quarters
FUN icon
65
Cedar Fair
FUN
$875M
$9.19M 0.55%
431,403
-994,764
-70% -$20.3M
2025 Q3
3 quarters
ROCK icon
66
Gibraltar Industries
ROCK
$1.17B
$9.17M 0.55%
203,383
+20,311
+11% +$796K
2026 Q1
1 quarter
SPT icon
67
Sprout Social
SPT
$701M
$8.19M 0.49%
1,085,404
-72,049
-6% -$469K
2025 Q1
5 quarters
BBY icon
68
Best Buy
BBY
$19.8B
$7.91M 0.47%
+104,275
New +$6.93M
2026 Q2
0 quarters
DMC icon
69
Del Monte Corp
DMC
$1.41B
$7.87M 0.47%
281,867
+109,625
+64% +$3.85M
2023 Q3
11 quarters
EPC icon
70
Edgewell Personal Care
EPC
$1.3B
$7.16M 0.43%
266,683
-228,065
-46% -$4.87M
2025 Q2
4 quarters
GOOS icon
71
Canada Goose Holdings
GOOS
$808M
$7.11M 0.42%
747,128
-109,125
-13% -$1.15M
2026 Q1
1 quarter
LOVE icon
72
LoveSac
LOVE
$213M
$6.9M 0.41%
413,318
-53,430
-11% -$845K
2025 Q4
2 quarters
OGG
73
Osisko Gold Group
OGG
$837M
$6.85M 0.41%
2,785,633
-778,153
-22% -$2.31M
2025 Q4
2 quarters
OTIS icon
74
Otis Worldwide
OTIS
$26.8B
$6.63M 0.4%
92,561
+28,509
+45% +$2.13M
2026 Q1
1 quarter
CLW icon
75
Clearwater Paper
CLW
$311M
$6.59M 0.39%
420,419
+116,269
+38% +$1.75M
2025 Q3
3 quarters

Similar funds

Invenomic Capital Management's Q2 2026 Portfolio in Review

As of Q2 2026, Invenomic Capital Management held 171 positions worth $1.67B, down 23% from $2.18B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Invenomic Capital Management withdrew a net $520M in Q2 2026, closing 55 positions and reducing 68 holdings. Its most notable exit was Chord Energy, an estimated $73.2M position sold in full.

By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 31% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Invenomic Capital Management opened a new position in Charter Communications worth $40.2M.

  • Invenomic Capital Management's largest Q2 2026 buy was Charter Communications: 282,416 shares worth $40.2M.
  • Invenomic Capital Management added most to Universal Health Services in Q2 2026, an estimated $39.4M increase.
  • Invenomic Capital Management's biggest Q2 2026 reduction was Haemonetics, cutting an estimated $28.8M.
  • Invenomic Capital Management fully exited Chord Energy in Q2 2026, selling an estimated $73.2M.
  • Invenomic Capital Management's ten largest holdings make up 29% of its $1.67B portfolio in Q2 2026.
  • Invenomic Capital Management opened 21 new positions and closed 55 in Q2 2026.
  • Invenomic Capital Management's portfolio value fell 23% quarter-over-quarter to $1.67B.

Based on Invenomic Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.